Mr. Speaker, I thank the member for Burnaby—Douglas for outlining some clear problems with this deeply flawed legislation.
Last November, the Ottawa Citizen had a lengthy editorial dealing with this bill stating that this was a bad law in pursuit of bad politics based on non-existent science, and Parliament should not go along.
The member for Vancouver East has put together some numbers. She said that Canada spends 73% of its drug policy budget on drug enforcement and only 14% on treatment, 7% on research, 2.6% on prevention and 2.6% on harm reduction. We have examples like Insite, for which the government is failing to announce any extension beyond the current time limit of June.
I wonder if the member could comment on some of the important elements around treatment and harm reduction that are simply missing in the drug policy we currently have in Canada.